ArticleThe Journal of clinical investigation2026

FBXO11 suppression rewires an NPM1-centered interactome influencing the progression of myelodysplastic syndrome.

Madeline Niederkorn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.